Increasing the radiochemical purity of 99mTc-sestamibi commercial preparations results in improved sensitivity of dual-phase planar parathyroid scintigraphy.
Ballinger
James R
JR
Cooper
Margaret S
MS
D000328:Adult; D000368:Aged; D004345:Drug Industry; D005260:Female; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D007091:Image Processing, Computer-Assisted; D007553:Isotope Labeling / Q000379:methods; D008297:Male; D008875:Middle Aged; D010279:Parathyroid Diseases / Q000175:diagnosis; D010282:Parathyroid Neoplasms / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging / Q000379:methods*; D019275:Radiopharmaceuticals / Q000032:analysis; D015203:Reproducibility of Results; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi / Q000032:analysis*; D013997:Time Factors
D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi